Corticotropin-releasing factor receptors in GtoPdb v.2023.1

  • Frank M. Dautzenberg Johnson & Johnson Pharmaceutical Research & Development
  • Dimitri E. Grigoriadis Neurocrine Biosciences
  • Richard L. Hauger University of California San Diego
  • Victoria B. Risbrough University of California San Diego
  • Thomas Steckler Johnson & Johnson Pharmaceutical Research & Development
  • Wylie W. Vale Salk Institute
  • Rita J. Valentino Children's Hospital of Philadelphia

Abstract


Corticotropin-releasing factor (CRF, nomenclature as agreed by the NC-IUPHAR subcommittee on Corticotropin-releasing Factor Receptors [34]) receptors are activated by the endogenous peptides corticotrophin-releasing hormone, a 41 amino-acid peptide, urocortin 1, 40 amino-acids, urocortin 2, 38 amino-acids and urocortin 3, 38 amino-acids. CRF1 and CRF2 receptors are activated non-selectively by CRH and UCN. CRF2 receptors are selectively activated by UCN2 and UCN3. Binding to CRF receptors can be conducted using radioligands [125I]Tyr0-CRF or [125I]Tyr0-sauvagine with Kd values of 0.1-0.4 nM. CRF1 and CRF2 receptors are non-selectively antagonized by α-helical CRF, D-Phe-CRF-(12-41) and astressin. CRF1 receptors are selectively antagonized by small molecules NBI27914, R121919, antalarmin, CP 154,526, CP 376,395. CRF2 receptors are selectively antagonized by antisauvagine and astressin 2B.

Published
26-Apr-2023
How to Cite
Dautzenberg, F. M., Grigoriadis, D. E., Hauger, R. L., Risbrough, V. B., Steckler, T., Vale, W. W. and Valentino, R. J. (2023) “Corticotropin-releasing factor receptors in GtoPdb v.2023.1”, IUPHAR/BPS Guide to Pharmacology CITE, 2023(1). doi: 10.2218/gtopdb/F19/2023.1.
Section
Summaries